Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk
- 20 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 64 (4), 826-835
- https://doi.org/10.1007/s00125-020-05358-3
Abstract
Aims/hypothesis We aimed to evaluate the relationship between childhood growth measures and risk of developing islet autoimmunity (IA) and type 1 diabetes in children with an affected first-degree relative and increased HLA-conferred risk. We hypothesised that being overweight or obese during childhood is associated with a greater risk of IA and type 1 diabetes. Methods Participants in a randomised infant feeding trial (N = 2149) were measured at 12 month intervals for weight and length/height and followed for IA (at least one positive out of insulin autoantibodies, islet antigen-2 autoantibody, GAD autoantibody and zinc transporter 8 autoantibody) and development of type 1 diabetes from birth to 10-14 years. In this secondary analysis, Cox proportional hazard regression models were adjusted for birthweight and length z score, sex, HLA risk, maternal type 1 diabetes, mode of delivery and breastfeeding duration, and stratified by residence region (Australia, Canada, Northern Europe, Southern Europe, Central Europe and the USA). Longitudinal exposures were studied both by time-varying Cox proportional hazard regression and by joint modelling. Multiple testing was considered using family-wise error rate at 0.05. Results In the Trial to Reduce IDDM in the Genetically at Risk (TRIGR) population, 305 (14.2%) developed IA and 172 (8%) developed type 1 diabetes. The proportions of children overweight (including obese) and obese only were 28% and 9% at 10 years, respectively. Annual growth measures were not associated with IA, but being overweight at 2-10 years of life was associated with a twofold increase in the development of type 1 diabetes (HR 2.39; 95% CI 1.46, 3.92; p < 0.001 in time-varying Cox regression), and similarly with joint modelling. Conclusions/interpretation In children at genetic risk of type 1 diabetes, being overweight at 2-10 years of age is associated with increased risk of progression from multiple IA to type 1 diabetes and with development of type 1 diabetes, but not with development of IA. Future studies should assess the impact of weight management strategies on these outcomes. Graphical abstractFunding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD051997)
This publication has 41 references indexed in Scilit:
- The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-upDiabetologia, 2010
- Dietary Intervention in Infancy and Later Signs of Beta-Cell AutoimmunityThe New England Journal of Medicine, 2010
- Height growth velocity, islet autoimmunity and type 1 diabetes development: the Diabetes Autoimmunity Study in the YoungDiabetologia, 2009
- Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration studyThe Lancet, 2009
- Predictors of Overweight During Childhood in Offspring of Parents With Type 1 DiabetesDiabetes Care, 2009
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort StudyPEDIATRICS, 2009
- Weight Gain in Early Life Predicts Risk of Islet Autoimmunity in Children With a First-Degree Relative With Type 1 DiabetesDiabetes Care, 2009
- Does the secular increase in body mass in children contribute to the increasing incidence of type 1 diabetes?Pediatric Diabetes, 2008
- Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary ReportPEDIATRICS, 2007
- Obesity in children and young people: a crisis in public healthObesity Reviews, 2004